During the Personalized Medicine Conference on May 10th and 20, Colin Hill will be participating in a fireside chat with MMRF CEO, Michael Andreini to talk to discuss the significance of cross-sector partnerships to the future of personalized medicine. They will be joined by William S. Dalton, Ph.D., M.D. Founder, Senir Advisor, M2Gen who will be moderating this session.
To keep up with the pace at which researchers are producing these data, leaders from multiple sectors of the health care system noted the importance of data-sharing partnerships that give both human and artificial intelligences an opportunity to scan a wider range of health care data in pursuit of more sophisticated personalized medicine strategies. This spirit of collaboration was the impetus for a promising partnership using GNS Healthcare‘s causal artificial intelligence platform to analyze longitudinal multi-modal patient registry data provided by the Multiple Myeloma Research Foundation (MMRF).